Spring direct naar de hoofdnavigatie of de inhoud
‘Different parts of patent law seem to a certain extent to conflict. I enjoy exploring the fault lines that such conflicts create. I am mindful of such fault lines when obtaining patents for my clients and strive to exploit them when defending my clients.’
Marlon Blood

Marlon Blood

  • Hightech & Electronics
  • European Patent Attorney
  • Senior Associate

Marlon Blood has worked for many years as IPR manager in Japan for one of the world’s leading mobile communication companies before joining V.O. In this capacity, he acquired substantial experience in contentious IP matters, including the assertion and defense of standard-related mobile communication patents and related litigation.

Continue reading

Marlon has substantial experience in IP acquisition, including pre-filing invention identification and evaluation, drafting, and prosecution. He has considerable experience in acting before the EPO in opposition and appeal proceedings.

Marlon’s current practice and previous experience encompass a broad range of technologies including mobile communication devices and networks, software, lasers, loudspeakers, mail processing systems, capsule-based coffee machines and angling equipment. He read electronic engineering at Reading University, UK.

Working experience

  • Patent Attorney, V.O (2009-present)
  • Patent Attorney, Private practice (2006-2009)
  • IPR Manager in one of the world’s leading telecommunication companies (1995-2005)
  • Patent Attorney, Private practice (1991-1995)

Education

  • BSc in Electronic Engineering, Reading University, UK

Languages

  • English
  • Japanese

Also see these experts

Raimondo Cau

Raimondo Cau

  • European and Dutch Patent Attorney
  • Senior Associate
Bart Jan Niestadt

Bart Jan Niestadt

  • European, Dutch and Belgian Patent Attorney, European Patent Litigator
  • Partner
More experts

News

EPO T 1149/25: technical skills and the technical-task requirement for therapy-selection GUIs 

In T 1149/25, decided by Technical Board of Appeal 3.5.05 of the European Patent Office (EPO) on 5 October 2026, the Board considered whether a graphical user interface (GUI) for therapy selection contributed to inventive step. Its reasoning distinguishes the medical expertise required to select a therapy from the technical task needed to establish the […]Continue reading

T 0384/25: adaptation of description not required in view of G1/25

In T 0384/25, decided on 11 September 2026, the Board of Appeal of the European Patent Office (EPO) allowed parts of the description relating to medical uses to remain in the description after the corresponding claims had been deleted. The decision provides a first example after G1/25 of a situation where the description does not […]Continue reading

Using IP as a financing instrument

For many businesses, patents, trade marks and registered designs are more than intellectual property rights. They represent company value, strengthen brand recognition and can constitute significant business assets. What is less widely known is that, under certain circumstances, these rights can also serve as collateral for bank financing.Continue reading